These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 21791486

  • 1. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D, Wang LM, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J.
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I.
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [Abstract] [Full Text] [Related]

  • 3. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
    Hörkkö TT, Klintrup K, Mäkinen JM, Näpänkangas JB, Tuominen HJ, Mäkelä J, Karttunen TJ, Mäkinen MJ.
    Eur J Cancer; 2006 May; 42(7):964-71. PubMed ID: 16563744
    [Abstract] [Full Text] [Related]

  • 4. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA, Kim SH, Hong HK, Yun SH, Kim HC, Chun HK, Cho YB, Lee WY.
    Oncology; 2014 May; 86(5-6):318-28. PubMed ID: 24924873
    [Abstract] [Full Text] [Related]

  • 5. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, Zhang X, Li J, Han X, Sun Y.
    Scand J Gastroenterol; 2008 May; 43(4):456-64. PubMed ID: 18365911
    [Abstract] [Full Text] [Related]

  • 6. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
    Ortega P, Morán A, de Juan C, Frías C, Hernández S, López-Asenjo JA, Sánchez-Pernaute A, Torres A, Iniesta P, Benito M.
    Clin Cancer Res; 2008 Feb 15; 14(4):995-1001. PubMed ID: 18281531
    [Abstract] [Full Text] [Related]

  • 7. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY.
    Ann Surg Oncol; 2007 May 15; 14(5):1703-11. PubMed ID: 17211730
    [Abstract] [Full Text] [Related]

  • 8. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.
    Clin Cancer Res; 2008 Jan 01; 14(1):143-8. PubMed ID: 18172264
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş.
    Pol J Pathol; 2011 Jan 01; 62(1):19-24. PubMed ID: 21574102
    [Abstract] [Full Text] [Related]

  • 10. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K, Konstantara A, Kotoula V, Lakis S, Kouvatseas G, Akriviadis E, Vrettou E, Dionysopoulos D, Krikelis D, Papadopoulou K, Charalambous E, Chrisafi S, Konstantaras C, Fountzilas G.
    Anticancer Res; 2013 Oct 01; 33(10):4573-84. PubMed ID: 24123033
    [Abstract] [Full Text] [Related]

  • 11. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
    Norwood MG, Bailey N, Nanji M, Gillies RS, Nicholson A, Ubhi S, Darnton JJ, Steyn RS, Womack C, Hughes A, Hemingway D, Harrison R, Waters R, Jankowski JA.
    Histopathology; 2010 Jul 01; 57(1):101-11. PubMed ID: 20572881
    [Abstract] [Full Text] [Related]

  • 12. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A, Laghi L, Bianchi P, Delconte G, Randolph A, Torri V, Carnaghi C, Doci R, Rosati R, Montorsi M, Roncalli M, Gennari L, Santoro A.
    Clin Cancer Res; 2007 Jul 01; 13(13):3831-9. PubMed ID: 17606714
    [Abstract] [Full Text] [Related]

  • 13. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM, Lugli A.
    Hum Pathol; 2011 Dec 01; 42(12):1888-96. PubMed ID: 21664646
    [Abstract] [Full Text] [Related]

  • 14. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM, Pandeya N, Cummings MC, Walsh MD, Young JP, Leggett BA, Purdie DM, Jass JR, Radford-Smith GL.
    J Pathol; 2003 Sep 01; 201(1):46-54. PubMed ID: 12950016
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.
    García-Solano J, Conesa-Zamora P, Trujillo-Santos J, Torres-Moreno D, Mäkinen MJ, Pérez-Guillermo M.
    Hum Pathol; 2012 Jul 01; 43(7):1094-102. PubMed ID: 22209340
    [Abstract] [Full Text] [Related]

  • 16. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.
    Oncology; 2009 Jul 01; 77(1):53-62. PubMed ID: 19556810
    [Abstract] [Full Text] [Related]

  • 17. Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.
    Mårtensson A, Oberg A, Jung A, Cederquist K, Stenling R, Palmqvist R.
    Oncol Rep; 2007 Feb 01; 17(2):447-52. PubMed ID: 17203186
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis is a new promising prognostic factor in colorectal cancer.
    Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, Langner C.
    Hum Pathol; 2010 Dec 01; 41(12):1749-57. PubMed ID: 20869096
    [Abstract] [Full Text] [Related]

  • 19. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P, Baker K, Baumhoer D, Terracciano L, Lugli A, Zlobec I.
    Hum Pathol; 2010 Jan 01; 41(1):70-8. PubMed ID: 19740518
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
    Oh SY, Kim YB, Suh KW, Paek OJ, Moon HY.
    J Surg Res; 2012 Jan 01; 172(1):102-8. PubMed ID: 20851411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.